Abstract
Many of the fibrogenic effects of transforming growth factor-beta (TGF-beta) might be mediated by connective tissue growth factor (CTGF). The present study investigates the role of mitogen-activated protein (MAP) kinase in the expression of CTGF mRNA in the human lung fibroblast line, HFL-1. TGF-beta1 enhanced CTGF mRNA levels in a time- and concentration-dependent manner, and this enhancement was also dependent upon transcription. Inhibition of p38 MAP kinase or extracellular signal-regulated kinase (ERK) activation did not affect TGF-beta1-induced CTGF expression. On the other hand, specific inhibitors of phosphatidylinositol 3-kinase (PI3K) suppressed TGF-beta1-induced CTGF expression in a concentration-dependent manner. TGF-beta1 activated c-Jun NH2-terminal kinase (JNK) and p38 MAP kinase, but not ERK in HFL-1 cells. PI3K inhibitors dose-dependently suppressed TGF-beta1-induced JNK, but not p38 MAP kinase activation. Finally, JNK1 and JNK2 antisense oligonucleotides attenuated cellular levels of JNK1 and JNK2 protein, respectively, and repressed TGF-beta1-induced CTGF expression. These results suggest that TGF-beta1-induced CTGF mRNA expression is mediated through the JNK-dependent pathway, whereas p38 MAP kinase and ERK pathways minimally contribute.
MeSH Terms
Androstadienes/pharmacology
Anthracenes/pharmacology
Cells, Cultured
Chromones/pharmacology
Connective Tissue Growth Factor
DNA-Binding Proteins/drug effects,metabolism
Enzyme Activation/drug effects
Enzyme Inhibitors/pharmacology
Fibroblasts/drug effects,metabolism
Gene Expression Regulation/drug effects
Humans
Imidazoles/pharmacology
Immediate-Early Proteins/drug effects,genetics,metabolism
Intercellular Signaling Peptides and Proteins/genetics,metabolism
JNK Mitogen-Activated Protein Kinases
Lung/cytology
Mitogen-Activated Protein Kinase 8
Mitogen-Activated Protein Kinase 9
Mitogen-Activated Protein Kinases/antagonists & inhibitors,drug effects,genetics,metabolism
Morpholines/pharmacology
Oligonucleotides, Antisense/pharmacology
Phosphatidylinositol 3-Kinases/metabolism
Phosphoinositide-3 Kinase Inhibitors
Phosphorylation/drug effects
Pyridines/pharmacology
RNA, Messenger/drug effects,metabolism
Smad2 Protein
Trans-Activators/drug effects,metabolism
Transforming Growth Factor beta/metabolism,pharmacology
Transforming Growth Factor beta1
Wortmannin
p38 Mitogen-Activated Protein Kinases
Chemicals
Androstadienes
Anthracenes
CCN2 protein, human
Chromones
DNA-Binding Proteins
Enzyme Inhibitors
Imidazoles
Immediate-Early Proteins
Intercellular Signaling Peptides and Proteins
Morpholines
Oligonucleotides, Antisense
Phosphoinositide-3 Kinase Inhibitors
Pyridines
RNA, Messenger
SMAD2 protein, human
Smad2 Protein
TGFB1 protein, human
Trans-Activators
Transforming Growth Factor beta
Transforming Growth Factor beta1
Connective Tissue Growth Factor
pyrazolanthrone
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one
Mitogen-Activated Protein Kinase 9
JNK Mitogen-Activated Protein Kinases
Mitogen-Activated Protein Kinase 8
Mitogen-Activated Protein Kinases
p38 Mitogen-Activated Protein Kinases
SB 203580
Wortmannin
Authors & Affiliations
7 authors, click to expand affiliations / ORCID
Utsugi Mitsuyoshi
First Department of Internal Medicine, Gunma University Faculty of Medicine, School of Medicine, 3-39-15 Showa-machi, Maebashi, Gunma, 371-8511, Japan. mutsugi@med.gunma-u.ac.jp
Dobashi Kunio
Ishizuka Tamotsu
Masubuchi Ken
Shimizu Yasuo
Nakazawa Tsugio
Mori Masatomo